One study demonstrated hypermethylation of the promoter and decreased levels of CYP19A1 mRNA and protein in PCOS ovaries, which indicated that the expression of aromatase was inhibited (Yu et al., 2013). Here, CYP19A1 is linked to polycystic ovary syndrome.